Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia

Shukaib Arslan; Jianying Zhang; Prajwal Dhakal; Jenna Moran; Nuthana Naidoo; Jennifer Lombardi; Vinod Pullarkat; Anthony S. Stein; Guido Marcucci; George Yaghmour; Vijaya R. Bhatt; Amir T. Fathi; Ibrahim Aldoss

doi:10.1002/ajh.26057

Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia

Shukaib Arslan, Jianying Zhang, Prajwal Dhakal, Jenna Moran, Nuthana Naidoo, Jennifer Lombardi, Vinod Pullarkat, Anthony S. Stein, Guido Marcucci, George Yaghmour, Vijaya R. Bhatt, Amir T. Fathi, Ibrahim Aldoss

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Journal	American Journal of Hematology
DOIs	https://doi.org/10.1002/ajh.26057
State	Accepted/In press - 2020

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.26057

Cite this

Arslan, S., Zhang, J., Dhakal, P., Moran, J., Naidoo, N., Lombardi, J., Pullarkat, V., Stein, A. S., Marcucci, G., Yaghmour, G., Bhatt, V. R., Fathi, A. T., & Aldoss, I. (Accepted/In press). Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia. American Journal of Hematology. https://doi.org/10.1002/ajh.26057

Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia. / Arslan, Shukaib; Zhang, Jianying; Dhakal, Prajwal; Moran, Jenna; Naidoo, Nuthana; Lombardi, Jennifer; Pullarkat, Vinod; Stein, Anthony S.; Marcucci, Guido; Yaghmour, George; Bhatt, Vijaya R.; Fathi, Amir T.; Aldoss, Ibrahim.

In: American Journal of Hematology, 2020.

Research output: Contribution to journal › Letter › peer-review

Arslan, Shukaib ; Zhang, Jianying ; Dhakal, Prajwal ; Moran, Jenna ; Naidoo, Nuthana ; Lombardi, Jennifer ; Pullarkat, Vinod ; Stein, Anthony S. ; Marcucci, Guido ; Yaghmour, George ; Bhatt, Vijaya R. ; Fathi, Amir T. ; Aldoss, Ibrahim. / Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia. In: American Journal of Hematology. 2020.

@article{70e3e102691446198ba6b0d016403654,

title = "Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia",

author = "Shukaib Arslan and Jianying Zhang and Prajwal Dhakal and Jenna Moran and Nuthana Naidoo and Jennifer Lombardi and Vinod Pullarkat and Stein, {Anthony S.} and Guido Marcucci and George Yaghmour and Bhatt, {Vijaya R.} and Fathi, {Amir T.} and Ibrahim Aldoss",

year = "2020",

doi = "10.1002/ajh.26057",

language = "English (US)",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia

AU - Arslan, Shukaib

AU - Zhang, Jianying

AU - Dhakal, Prajwal

AU - Moran, Jenna

AU - Naidoo, Nuthana

AU - Lombardi, Jennifer

AU - Pullarkat, Vinod

AU - Stein, Anthony S.

AU - Marcucci, Guido

AU - Yaghmour, George

AU - Bhatt, Vijaya R.

AU - Fathi, Amir T.

AU - Aldoss, Ibrahim

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85097309604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097309604&partnerID=8YFLogxK

U2 - 10.1002/ajh.26057

DO - 10.1002/ajh.26057

M3 - Letter

C2 - 33227142

AN - SCOPUS:85097309604

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

ER -